Recognition of breast cancer-associated peptides by tumor-reactive, HLA- class I restricted allogeneic cytotoxic T lymphocytes

International Journal of Cancer

Volumn 81, Issue 4, 1999, Pages 607-615

  Nguyen, Thelinh ^a   Naziruddin, Bashoo ^a   Dintzis, Suzanne ^a   Doherty, Gerard M ^a   Mohanakumar, T ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; BREAST CANCER; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SCID MOUSE; TUMOR ASSOCIATED LEUKOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; BREAST NEOPLASMS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOHISTOCHEMISTRY; ISOANTIGENS; MICE; MICE, SCID; PEPTIDES; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0032908539     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990517)81:4<607::AID-IJC17>3.0.CO;2-X     Document Type: Article

References (21)

1. BALDO, M., SCHIAVON, M., CICOGNA, P.A., BOCCATO, P. and MAZZOLENI, F., Spontaneous regression of subcutaneous metastasis of cutaneous melanoma. Plastic Reconstruct. Surg., 90, 1073-1076 (1992).
2. BOON, T. and VAN DER BRUGGEN, P., Human tumor antigens recognized by T lymphocytes. J. exp. Med., 183, 725-729 (1996).
3. BRÉCHOT, J.M., CHEVRET, S., NATAF, J., LE GALL, C., FRETAULT, J., ROCHEMAURE, J. and CHASTANG, C., Diagnostic and prognostic value of Cyfra 21-1 compared with other tumour markers in patients with non-small cell lung cancer: a prospective study of 116 patients. Europ. J. Cancer, 33, 385-391 (1997).
4. CHEN, Q. and HERSEY, P., MHC-restricted responses of CD8+ and CD4+ T-cell clones from regional lymph nodes of melanoma patients. Int. J. Cancer, 51, 218-224 (1992).
5. COX, A.L., SKIPPER, J., CHEN, Y., HENDERSON, R.A., DARROW, T.L., SHABANOWITZ, J., ENGELHARD, V.H., HUNT, D. and SLINGLUFF, C.L., Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science, 264, 716-719 (1994).
6. FALK, K., ROTZSCHKE, O., STEVANOVIC, S., JUNG, G. and RAMMENSEE, H., Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature (Lund.), 351, 2901-2904 (1991).
7. GJERTSEN, M.K., BREIVIK, J., SAETERDAL, I., SOLHEIM, B.G., SOREIDE, O., THORSBY, E. and GAUDERNACK, G., Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation. Lancet, 346, 1399-1400 (1995).
8. GURE, A.O., ALTORKI, N.K., STOCKERT, E., SCANLAN, M.J., OLD, L.J. and CHEN, Y.T., Human lung cancer antigens recognized by autologous antibodies: definition of a noval cDNA derived from the tumor suppressor gene locus on chromosome 3p2l .3. Cancer Res., 58, 1034-1041 (1998).
9. HADLEY, G.A. and MOHANAKUMAR, T., Immunogenicity of MHC class I alloantigens expressed on parenchymal cells in the human kidney. Transplantation, 54, 537-543 (1992).
10. JORGENSEN J.L., REAY, P.A., EHRICH, E.W. and DAVIS, M.M., Molecular components of T-cell recognition. Ann. Rev. Immunol., 10, 835-873 (1992).
11. KANG, N., TRUMAN, H., SANDERS, R. and KUPSCH, J., Melanoma antigens and targets for vaccination. Brit. J. Hosp. Med., 58, 282-286 (1997).
12. KOTERA, Y., FONTENOT, J.D., PECHER, G., METZOAR, R.S. and FINN, O.J., Humoral immunity against a tandem repeat epitope of human mucin MUC-I in sera from breast, pancreatic and colon cancer patients. Cancer Res., 54, 2856-2860 (1994).
13. LINEHAN, D.C., GOEDEGEBUURE, P.S., PEOPLE, G.E., ROGERS, S.O. and EBERLEIN, T.J., Tumor-specific and HLA-A2-restricted cytolysis by tumor associated lymphocytes in human metastatic breast cancer. J. Immunol., 155, 4486-4491 (1995).
14. MAEURER, M.J., GOLLIN, S.M., MARTIN, D., SWANEY, W., BRYANT, J., CASTELLI, C., ROBBINS, P., PARMIANI, G., STORKUS, W.J. and LOTZE, M.T., Tumor escape from immune recognition. J. clin. Invest., 98, 1633-1641 (1996).
15. MAXWELL-ARMSTRONG, C.A., DURRANT, L.G. and SCHOLEFIELD, J.H., Colorectal cancer vaccines. Brit. J. Surg., 85, 149-154 (1998).
16. PEACE, D.J., SMITH, J.W., CHEN, W., You, S.G., COSAND, W.L., BLAKE, J. and CHEEVER, M.A., Lysis of a ras oncogene-transformed cells by specific cytotoxic T-lymphocytes elicited by primary in vitro immunization with mutated ras peptide. J. exp. Med., 179, 473-479 (1994).
17. PEOPLES, G.E., GOEDEGEBUURE, P.S., SMITH, R., LINEHAN, D.C., YOSHINO, I. and EBERLEIN, T.J., Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide. Proc. nat. Acad. Sci. (Wash.), 92, 432-436 (1995).
18. POINDEXTER, N.J., NAZIRUDDIN, B., MCCOURT, D.W. and MOHANAKUMAR, T., Isolation of a kidney-specific peptide recognized by alloreactive HLA-A3-restricted human CTL. J. Immunol., 154, 3880-3887 (1995).
19. RAMMENSEE, H., FRIEDE, T. and STEVANOVIC, S., MHC ligands and peptide motifs: first listing. Immunogenetics, 41, 178-228 (1995).
20. SAARIALHO-KERE, U.K., KOVACS, A.P., PENTLAND, J.E., OLERUD, H.G., WELGUS, H.G. and PARKS, W.C., Cell-matrix interactions modulate interstitial collegenase expression by human keratinocytes actively involved in wound healing. J. clin. Invest., 92, 2858-2866 (1993).
21. WHICKER, J.H., DEMARCO, P.R. and FITZGIBBONS, J.F., Spontaneous regression of a facial malignant melanoma. Arch. Otolaryngol., 106, 50-51 (1980).